Omada Health (NASDAQ:OMDA) Stock Price Down 9.3% – Should You Sell?

Omada Health, Inc. (NASDAQ:OMDA) shares were down 9.3% during mid-day trading on Friday . The stock traded as low as $14.94 and last traded at $14.8730. Approximately 1,825,262 shares changed hands during trading, an increase of 50% from the average daily volume of 1,218,513 shares. The stock had previously closed at $16.40.

Omada Health News Roundup

Here are the key news stories impacting Omada Health this week:

• Positive Sentiment: Barclays raised its price target on Omada Health and kept an overweight rating, pointing to meaningful upside from current levels. Barclays raises OMDA price target
• Positive Sentiment: Citizens JMP also boosted its target and reiterated a market outperform rating, adding to the bullish analyst sentiment around OMDA. Citizens JMP raises OMDA price target
• Positive Sentiment: Wells Fargo lifted its target as well, suggesting Wall Street sees more room for Omada Health despite maintaining an equal-weight view. Wells Fargo raises OMDA price target
• Positive Sentiment: Needham reaffirmed its buy rating and set a much higher target, reinforcing confidence in Omada’s growth outlook. Needham reiterates buy rating on OMDA
• Positive Sentiment: Omada reported Q1 EPS of -$0.05, beating expectations for a smaller loss than analysts projected, while revenue came in at $78.05 million. Omada Q1 2026 earnings report
• Positive Sentiment: The company raised FY2026 revenue guidance to $322 million-$330 million, above the Street’s estimate, signaling stronger expected top-line growth. Omada FY2026 guidance update
• Positive Sentiment: Omada announced it will join Lilly Employer Connect as an independent program administrator, expanding access for its GLP-1 care services and potentially broadening future demand. Omada Health Lilly Employer Connect announcement

Analyst Ratings Changes

Several research firms have recently weighed in on OMDA. Wall Street Zen raised shares of Omada Health from a “hold” rating to a “buy” rating in a research note on Saturday, March 14th. Morgan Stanley cut their price objective on shares of Omada Health from $32.00 to $30.00 and set an “overweight” rating for the company in a report on Friday, March 6th. Weiss Ratings restated a “sell (d)” rating on shares of Omada Health in a report on Thursday, January 22nd. Evercore reaffirmed an “outperform” rating and issued a $20.00 price target on shares of Omada Health in a report on Friday. Finally, The Goldman Sachs Group reiterated a “buy” rating on shares of Omada Health in a research report on Friday. Ten research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $22.91.

Omada Health Stock Down 9.6%

The company’s 50-day moving average is $13.55 and its 200-day moving average is $15.85. The stock has a market capitalization of $880.60 million and a price-to-earnings ratio of -54.89.

Omada Health (NASDAQ:OMDA) last posted its earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.08) by $0.03. The company had revenue of $78.05 million for the quarter. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.85%. Sell-side analysts anticipate that Omada Health, Inc. will post -0.04 EPS for the current year.

Insider Activity at Omada Health

In other Omada Health news, CFO Steven L. Cook sold 1,884 shares of Omada Health stock in a transaction on Friday, March 13th. The stock was sold at an average price of $13.94, for a total value of $26,262.96. Following the sale, the chief financial officer owned 200,512 shares in the company, valued at $2,795,137.28. The trade was a 0.93% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Sean P. Duffy sold 4,063 shares of the company’s stock in a transaction on Monday, March 9th. The shares were sold at an average price of $14.34, for a total value of $58,263.42. Following the completion of the transaction, the chief executive officer directly owned 117,598 shares in the company, valued at approximately $1,686,355.32. This trade represents a 3.34% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 8,776 shares of company stock worth $120,483.

Institutional Trading of Omada Health

A number of hedge funds and other institutional investors have recently modified their holdings of OMDA. Quarry LP acquired a new position in Omada Health in the fourth quarter valued at about $29,000. TD Waterhouse Canada Inc. acquired a new stake in shares of Omada Health during the fourth quarter valued at about $32,000. Raymond James Financial Inc. purchased a new stake in shares of Omada Health in the 2nd quarter valued at approximately $32,000. Strs Ohio acquired a new position in shares of Omada Health in the 3rd quarter worth approximately $38,000. Finally, Inlight Wealth Management LLC acquired a new position in shares of Omada Health in the 4th quarter worth approximately $45,000.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.